neuronal circuits — insights that inform next-generation functional assay development and translational therapeutic collaborative chemistry enabled in designing receptor-targeted fluorescent ligands The moment when structural

Whether a 20% reduction in beta-arrestin coupling matters therapeutically depends on the cell type, the Antibody therapeutics for GPCRs: the pipeline argument Biologics have a substantially higher success The combination of those two facts, Gilchrist argues, makes antibody-based GPCR therapeutics an underexplored The precedent of drugging a receptor without knowing what activates it naturally, and getting therapeutic "As much as it's been wonderful to get crystal structures and use molecular dynamics, there are still

specialty - it is a conserved principle The central argument of Arey's 2014 book is that the bimodal structure Arey arrived at this hypothesis in the mid-1990s, before the structural and mechanistic data existed He argues for a therapeutic strategy built around modulators that can be combined, rather than single His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

Rho, YAP, and the druggable FAK node CXCR3 and the chemokine axis that gates immunotherapy response Structural The canonical assumption that targeting PLC would be therapeutic has failed in the clinic, and patients Team science is structural, not decorative. responds to checkpoint inhibitors 20:28 GαQ, uveal melanoma, and the failure of the textbook pathway 41:27 Structural

Schwartz, and worked closely with Dr Birgitte Holst studying structural and mechanistic properties of Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations

Xenopus oocytes, electrophysiology, molecular pharmacology, and the use of informatics to mine sequence, structural The CGRP story illustrates how structural biology and pharmacology intersect with corporate decisions Later hepatotoxicity concerns and the success of antibody therapeutics further shifted strategy. He argues that integrating structural biology, computational pharmacology, and genetics may still be

the most clinically validated targets in metabolic disease - yet the signaling logic separating the therapeutic pharmacologists have not yet addressed actually shape signaling output at one of the field's most important therapeutic receptor Transducer coupling as the missing mechanistic layer in GLP-1 receptor pharmacology The expanding therapeutic modulate the functional output at this receptor, and whether that regulatory layer contributes to the therapeutic Working alongside structural biologists, computational pharmacologists, and receptor scientists working

has reached only about 166 of them, leaving more than 250 receptors unstudied at anything close to therapeutic Nikolaus Heveker's lab at the CHU Sainte-Justine Research Center on chemokine receptor structure–function Splice variants aren't just structural — they signal differently. During the past 2 decades, my research mainly focused on chemokine receptor structure/function relationships

and growing Free samples for GPCR researchers who will test the antibodies in their own labs and give structured Each session explores mechanistic models, translational challenges, and real-world therapeutic implications GPCR pharmacology, signaling, structural biology, allosteric modulation, biased agonism, assay design

response to human bias in the data - Vector behavior disruption as an alternative to pathogen specific therapeutics Instead, expression was almost exclusive to the mosquito rectum, a structure Duvall says she did not receptor could block all of these pathogens at their point of transmission, rather than requiring a therapeutic

He earned his PhD at MIT in the laboratory of Lawrence Stern, where he studied structure-function relationships He earned his Ph.D. at the Massachusetts Institute of Technology, where he studied MHC class II structure-function record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics

Jacobson, Matteo Pavan Structure-Based Design of Modulators of Purinergic GPCRs <p class="font_8">Watch Unconventional GPCR Ligands <p class="font_8">Watch Now</p> Terry Kenakin The New Frontier of GPCR Therapeutics

GPR56 as a mechanical sensor and his sustained case for the KLF2 signaling pathway as a GPCR-linked therapeutic creative and most invisible space in pharmaceutical research Arey describes early-stage drug discovery as structurally His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential signaling and drug discovery Symposium & Workshop - Brazil NEW April 1 - 3, 2025 | 2nd Peptide-Based Therapeutics Summit - USA April 2 - 3, 2025 | New therapeutic modalities: Transforming receptor pharmacology - UK Biologist - Confo Therapeutics Associate Director/Director, Platform & Hit-ID Chemistry Lead - Septerna Pharmacologist - Schrödinger Scientist - Biology - Superluminal Medicines Scientist I Cell Biology - Tectonic Therapeutic

This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream As the field advances, the computational layer — including AlphaFold and structural prediction tools

Pradhan turns to the structural weight carried by women and scientists of color in academia — the cumulative Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic

. 🗓️ Upcoming 4-Week Course: Development of GPCR Ligands as Therapeutic Drugs starting March 20 – April biotechs public Aikium's AI-Driven mRNA Engine Looks to Address Undruggable Disordered Proteins Tectonic Therapeutic - 21, 2025 | 2nd GPCR signaling and drug discovery Symposium & Workshop NEW April 2 - 3, 2025 | New therapeutic Pharmacology 2025 July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Structural PhD Position GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic

characterization applied to notoriously difficult receptor targets Recombinant monoclonal antibodies as the structural research 36:55 If not antibodies - Ball and Lin on the power of scientific communication 39:40 The GPCR therapeutic

of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics able to work with him and his team and use the tools developed in his lab to better understand GPCR structure

Pina Cardarelli, CSO for GPCR Therapeutics Inc., based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology company in the Bay Area. The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers She was an integral contributor to two therapeutics that are FDA approved, Yervoy and Opdivo. patents including anti-PD-1 patents, 22 EP patents, and greater than 100 global patents centered around therapeutic

collaborative neuroscience R&D program with Servier (France) and is the co-founder and CEO of Phrenix Therapeutics , a biotech spin-out from the Neuromedicines Discovery Centre that is developing next-generation therapeutics Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology These successes enabled the US$400M sale of Heptares Therapeutics Ltd. to the Sosei Group Corporation

He is pioneering the investigation of animal toxins acting on GPCRs, the largest therapeutic target class His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations pharmacological properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic

I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical chemistry. 6 years ago I decided to take on a new challenge by taking the position of CSO at Confo Therapeutics Christel Menet on the web Hyphen Projects GPCRS Drug Discovery Confo Therapeutics LinkedIn Dr.

He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics of GPCRs in disease states to help test the feasibility of using protein-targeted degradation as a therapeutic Maddi is currently a second year Ph.D. student in the Molecular Pharmacology and Therapeutics (MPaT)

regulate over 800 receptors, why "non-canonical" GPCRs are nature's own biased receptors, and building a structural How two structurally similar proteins orchestrate such functional diversity across an entire receptor His research focuses on the structural and functional basis of GPCR–beta-arrestin interactions, combining Scientific Themes of the Conversation The structural and functional basis of GPCR–beta-arrestin coupling Episode Timeline 00:00 Introduction 02:15 From DNA quadruplexes to GPCR structural biology 06:32 The

At UCSF, he develops structural models of GPCRs using sparse experimental data - combining restraints His research focuses on predicting GPCR structural ensembles from limited experimental data and using He trained as a structural biologist at Vanderbilt University, working with X-ray crystallography, protein They may vary slightly from the final edited version. 00:00 Introduction 01:31 From structural biology Brain’s work there primarily focused on structure prediction of GPCRs from sparse experimental data.

With a deep focus on structure-based drug design, Jens discusses how his lab bridges simulation and experiment—and From virtual screening of billions of molecules to leveraging AlphaFold for structure prediction, Jens You’ll Learn Why Jens Carlsson believes modeling should predict , not just explain How his team uses structure-based collaborations between modelers and experimentalists are more vital than ever How AlphaFold is shaking up structural a research career Who Should Listen GPCR scientists and pharmacologists Computational chemists and structural

Antonella Di Pizio on building computational models for GPCRs with almost no crystal structures and almost No crystal structures exist for most of them, sequence identity within the TAS2R family hovers between her PhD in computational medicinal chemistry before spending a formative period in Gerhard Klebe's structural Unlike bitter taste receptors, which share only 5–10% sequence identity with available structural templates relations based on the structure of the receptor."

Its discovery and characterization have led to the development of GLP-1 receptor agonists, a therapeutic emphasis on identifying compounds that modulate neural signaling pathways and may serve as leads for therapeutic

With hundreds of subtypes and very few known ligands, the structure–function relationships remain largely .” – Alessandro Nicoli He explained how AlphaFold’s predictions, surprisingly close to experimental structures More structures, better tools, and deeper insights into the elegant, complex world of GPCRs. By bridging structural prediction, molecular dynamics, and ligand discovery, his work not only deciphers Alessandro PhD work aims to fill these gaps by leveraging computational structure-based tools and develop